扑热息痛市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

Publication Month : Feb 2024

  • Report Code : TIPRE00038952
  • Category : Pharmaceuticals
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

【研究报告】扑热息痛市场预计将从2022年的99.9329亿美元增长到2030年的142.5444亿美元;预计 2022 年至 2030 年市场复合年增长率为 4.5%。
市场洞察和分析师观点:
扑热息痛是一种非处方非阿片类镇痛解热药物。它广泛用于治疗发烧和轻度至中度疼痛。扑热息痛有多种形式出售,包括片剂、胶囊、可溶性粉末和液体。一些常见的扑热息痛品牌包括 Calpol、Disprol、Hedex、Medinol 和 Panadol。疼痛和发烧的高发病率以及消费者对非处方药(OTC)的偏好不断增加是推动扑热息痛市场增长的关键因素。然而,对乙酰氨基酚过量的影响阻碍了市场的进步。
增长动力和限制:
与疼痛相关的疾病和发烧的发病率不断增加,推动了对乙酰氨基酚的市场规模。扑热息痛通常用于缓解轻度至中度疼痛和控制发烧,效果显着。根据美国食品和药物管理局 (FDA) 的数据,对乙酰氨基酚(扑热息痛)是治疗发烧和疼痛的首选药物。传染病的高流行加剧了对乙酰氨基酚的需求。据世界卫生组织 (WHO) 统计,季节性流感每年在全球造成 290,000-650,000 人死亡。同样,根据 CDC 估计,2010 年至 2022 年期间,美国流感引起的疾病病例从 940 万增加到 4100 万。扑热息痛与其他药物结合使用可治疗咳嗽、感冒、流感和过敏等疾病。同样,含有扑热息痛和其他活性成分的组合药物被广泛用于治疗严重疼痛。例如,它与尼美舒利或双氯芬酸组合用于治疗发烧、肌肉疼痛、牙痛、头痛、强直性脊柱炎、轻度偏头痛、类风湿性关节炎、骨关节炎和痛经等病症。同样,扑热息痛与醋氯芬酸和沙雷肽酶结合使用,可以减轻肌肉疼痛、术后疼痛、关节疼痛和其他病症的肿胀和疼痛。因此,随着此类健康问题在全球范围内的患病率持续上升,对扑热息痛作为一种广泛信任且易于使用的止痛选择的需求对其需求做出了重大贡献。
然而,潜在的副作用对扑热息痛市场具有重大影响。扑热息痛或对乙酰氨基酚用于缓解疼痛和发烧。尽管扑热息痛被广泛使用,并且按照指示使用通常被认为是安全的,但其使用仍存在一些特定的副作用和担忧。与扑热息痛相关的最显着的副作用之一是过量或使用不当时存在肝损伤的风险。这是一个主要问题,可能会影响消费者对产品的信心,可能导致使用量减少。根据 2022 年在 ScienceDirect 杂志上发表的研究“尼日利亚使用的扑热息痛剂量方案与美国使用的扑热息痛剂量方案的潜在有害影响”,扑热息痛是美国和欧洲急性肝衰竭的已知原因之一。同一消息来源报道说,扑热息痛中毒可能是尼日利亚肝脏疾病的原因。因此,对乙酰氨基酚的副作用阻碍了对乙酰氨基酚市场的增长。
战略见解
报告细分和范围:
“对乙酰氨基酚市场分析”是通过考虑以下细分市场进行的:剂型、适应症、给药途径和分销渠道。根据剂型,扑热息痛市场分为片剂、胶囊等。按适应症,市场分为发热、感冒咳嗽、轻度和中度疼痛等。根据给药途径,市场分为肠内和肠外。从分销渠道来看,市场分为医院药店、零售药店和网上药店。从地理上看,市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、韩国、亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和其他地区)南美洲和中美洲)。
细分分析:
根据剂型,扑热息痛市场分为片剂、胶囊等。片剂细分市场在 2022 年占据最大的市场份额,预计 2022 年至 2030 年复合年增长率最高。
扑热息痛市场,按剂型 – 2022 年和 2030 年
根据迹象,市场分为发烧类、感冒咳嗽、轻度和中度疼痛等。发热细分市场在 2022 年占据最大的市场份额。预计轻度和中度细分市场从 2022 年到 2030 年的复合年增长率最高。
根据给药途径,扑热息痛市场分为肠内和肠外。 2022年,肠内用药市场份额更大,预计2022-2030年复合年增长率更高。
根据分销渠道,扑热息痛市场分为医院药房、零售药房和网上药房。 2022 年,零售药房领域占据最大的市场份额,预计 2022 年至 2030 年复合年增长率最高。
区域分析:
扑热息痛市场报告的范围包括北美、欧洲、亚太地区、南美洲和中美洲以及中东和非洲。 2022年,北美占据全球最大的扑热息痛市场份额。美国各地医疗基础设施的发展、传染病的流行以及医疗保健服务支出的增加是该地区市场增长的推动因素。根据美国卫生与公众服务部的数据,每年有 3-11% 的美国人受到感染并出现流感症状。根据 2020 年 7 月发布的全球疾病负担研究结果,美国非传染性疾病和传染病负担巨大且不断增加。据约翰霍普金斯大学称,近二十年来,美国SARS、莱姆病、登革热、西尼罗河病毒、寨卡病毒等疾病感染病例迅速增加。同一消息来源证实,疟疾、结核病、霍乱、百日咳、流感、肺炎球菌病和淋病等疾病的发病率有所增加。扑热息痛和其他用于抑制发烧和类似症状的药物被用作传染病治疗的一部分。因此,传染病发病率的上升增加了美国对扑热息痛的需求,促进了扑热息痛市场份额的扩大。
行业发展和未来机遇:
扑热息痛市场预测可以帮助该市场的利益相关者规划他们的计划增长战略。以下列出了全球扑热息痛市场主要参与者采取的一些举措:
2023 年 10 月,爱尔兰心理健康和老年人部长发起了一项新活动,以促进药房和非药房零售中扑热息痛的安全销售设置。该活动的发起是为了让员工从这些环境中获得新的信息。该计划还旨在提高爱尔兰药房和非药房零售人员对与扑热息痛相关的故意用药过量的认识。 2022 年 4 月,IOL Chemicals & Pharmaceuticals Ltd 开始商业化生产“扑热息痛”,装机容量为 1800 MTPA,对氨基苯酚 (PAP) 的向后整合。该公司在其现有的 4 号装置中生产扑热息痛,该装置已改建为多产品设施,耗资约 120 万美元(近 1 亿印度卢比)。另一方面,PAP正在9号机组的一部分生产。公司将根据市场情况继续使用4号和9号机组生产其他产品。2022年3月,Paraveganio成为世界上第一个注册的药品纯素协会批准的纯素商标。扑热息痛片剂通常含有硬脂酸镁,起到流量调节剂的作用。它是一种硬脂酸和镁盐,可能源自动物。 Axunio 的 Paraveganio 含有完全源自蔬菜的硬脂酸镁。 2021 年 7 月,Hyloris Pharmaceuticals SA 宣布在德国和奥地利推出 Maxigesic IV。 Maxigesic IV 是一种新颖的、专利的、非阿片类药物治疗术后疼痛的药物,是 1,000 毫克扑热息痛和 300 毫克布洛芬输注溶液的独特组合。 Hyloris 和 AFT Pharmaceuticals(Hyloris 的合作伙伴)拥有多个在当地拥有强大影响力的分销合作伙伴,这有助于他们在全球范围内将产品商业化。竞争格局和主要公司:
Mallinckrodt Pharmaceuticals;葛兰素史克公司;梯瓦制药工业有限公司;太阳制药;赛诺菲;微型实验室有限公司;西普拉公司; B.布劳恩医疗公司;雷迪博士实验室有限公司;和费森尤斯·卡比 (Fresenius Kabi) 是扑热息痛市场报告中介绍的著名参与者之一。此外,研究期间还对其他几家参与者进行了研究和分析,以全面了解市场及其生态系统。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which dosage form segment dominates the paracetamol market?

Based on dosage form, the paracetamol market is segmented into tablets, capsules, and others. The tablets segment accounted for the largest market share in 2022. It is estimated to register the highest CAGR during 2022–2030.

Which route of administration segment dominates the paracetamol market?

Based on the route of administration, the paracetamol market is bifurcated into enteral and parenteral. In 2022, the enteral segment held a larger market share, and the same segment is anticipated to register a higher CAGR during 2022–2030.

What are the growth estimates for the paracetamol market till 2030?

The paracetamol market is expected to be valued at US$ 14,254.44 million in 2030.

Who are the major players in the paracetamol market?

The paracetamol market majorly consists of the players, including Mallinckrodt Pharmaceuticals; GSK plc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceuticals; Sanofi; Micro Labs Limited; Cipla Inc.; B. Braun Medical Inc.; Dr. Reddy’s Laboratories Ltd; and Fresenius Kabi.

What is paracetamol?

Paracetamol is an over the counter non-opioid analgesic and antipyretic medication. It is widely used to treat fever and mild-to-moderate pain. Paracetamol is sold in various forms, including tablets, capsules, soluble powders, and liquids. A few of the common brands of paracetamol include Calpol, Disprol, Hedex, Medinol, and Panadol.

What factors drive the paracetamol market?

The high prevalence of pain and fever conditions, and rising consumer preference for over-the-counter (OTC) medications are the key factors driving the paracetamol market growth.

What was the estimated paracetamol market size in 2022?

The paracetamol market was valued at US$ 9,993.29 million in 2022.

Which distribution channel segment dominates the paracetamol market?

Based on distribution channel, the paracetamol market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment held the largest market share. It is anticipated to register the highest CAGR during 2022–2030.

Which indication segment dominates the paracetamol market?

Based on indication, the market is segmented into fever, cold and cough, mild and moderate pain, and others. The fever segment held the largest market share in 2022. The mild and moderate segment is anticipated to register the highest CAGR from 2022 to 2030.

The List of Companies - Paracetamol Market

  1. Mallinckrodt Pharmaceuticals
  2. GSK plc
  3. Teva Pharmaceutical Industries Ltd.
  4. Sun Pharmaceuticals
  5. Sanofi
  6. Micro Labs Limited
  7. Cipla Inc
  8. B. Braun Medical Inc.
  9. Dr. Reddy’s Laboratories Ltd
  10. Fresenius Kabi

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports